electroCore (ECOR) Total Debt (2017 - 2026)
electroCore (ECOR) posted Total Debt of $7.8 million for Q2 2026, up 11.98% on a QoQ basis from $6.9 million in Q1 2026.
Analysis
electroCore (ECOR) Total Debt (2017 - 2026) Analysis & Trends
electroCore has reported Total Debt for 6 years, with the latest figure at $7.8 million in Q2 2026.
- On a quarterly basis, Total Debt changed N/A year-over-year to $7.8 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.6 million, changed N/A from the prior year.
- Total Debt was $7.8 million for Q2 2026 at electroCore, up from $6.9 million in the prior quarter.
- The five-year high for Total Debt was $7.8 million in Q2 2026, with the low at $6.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 28.15 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.94 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 12.62 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 4.15 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 2.14 Bn |
| 10 | electroCore | 87.36 Mn | 77.32 Mn | 8.18 Mn | 7.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.77 Mn |
| Mar 31, 2026 | 6.94 Mn |
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Mar 31, 2021 | 1.41 Mn |
| Dec 31, 2020 | 1.41 Mn |
| Sep 30, 2020 | 2.06 Mn |
| Jun 30, 2020 | 1.41 Mn |
| Dec 31, 2019 | 111,878.00 |
| Sep 30, 2019 | 461,341.00 |
| Dec 31, 2017 | 2.24 Mn |